Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Planta Medica
|
May 8, 1999
Vasodilatory effect in rat aorta of eriodictyol obtained from Satureja obovata
V Ramón Sánchez de Rojas, B Somoza, T Ortega, et al.
Preventive Medicine
|
September 1, 1980
Cord blood lipids and lipoproteins: Merida, Venezuela, and Cincinnati, Ohio
H Nucete, S Mendoza, B Somoza, et al.
Hypertension (Dallas, Tex. : 1979)
|
May 23, 2001
Differential effect of chronic antihypertensive treatment on vascular smooth muscle cell phenotype in spontaneously hypertensive rats
R Bravo, B Somoza, M Ruiz-Gayo, et al.
Vascular Pharmacology
|
April 15, 2015
Vascular AMPK as an attractive target in the treatment of vascular complications of obesity
C F García-Prieto, M Gil-Ortega, I Aránguez, et al.
British Journal of Pharmacology
|
February 3, 2017
Role of PVAT in coronary atherosclerosis and vein graft patency: friend or foe?
M S Fernández-Alfonso, M Gil-Ortega, I Aranguez, et al.
Atherosclerosis
|
October 1, 1980
Lipids and lipoproteins in 13--18-year-old Venezuelan and American school children. Within- and cross-cultural comparisons
S Mendoza, H Nucete, A Zerpa, et al.
Physiological Research
|
December 4, 2014
Effect of fetal undernutrition and postnatal overfeeding on rat adipose tissue and organ growth at early stages of postnatal development
D Munoz-Valverde, P Rodríguez-Rodríguez, P Y Gutierrez-Arzapalo, et al.
British Journal of Pharmacology
|
June 16, 2015
Genetic predisposition to albuminuria is associated with increased arterial stiffness: role of elastin
M Gil-Ortega, C F García-Prieto, G Ruiz-Hurtado, et al.
Vascular Pharmacology
|
December 23, 2014
Mild caloric restriction reduces blood pressure and activates endothelial AMPK-PI3K-Akt-eNOS pathway in obese Zucker rats
C F García-Prieto, H Pulido-Olmo, G Ruiz-Hurtado, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
October 13, 2023
Finerenone protects against progression of kidney and cardiovascular damage in a model of type 1 diabetes through modulation of proinflammatory and osteogenic factors
M Sanz-Gómez, F J Manzano-Lista, E Vega-Martín, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Planta Medica
|
May 8, 1999
Vasodilatory effect in rat aorta of eriodictyol obtained from Satureja obovata
V Ramón Sánchez de Rojas, B Somoza, T Ortega, et al.
Preventive Medicine
|
September 1, 1980
Cord blood lipids and lipoproteins: Merida, Venezuela, and Cincinnati, Ohio
H Nucete, S Mendoza, B Somoza, et al.
Hypertension (Dallas, Tex. : 1979)
|
May 23, 2001
Differential effect of chronic antihypertensive treatment on vascular smooth muscle cell phenotype in spontaneously hypertensive rats
R Bravo, B Somoza, M Ruiz-Gayo, et al.
Vascular Pharmacology
|
April 15, 2015
Vascular AMPK as an attractive target in the treatment of vascular complications of obesity
C F García-Prieto, M Gil-Ortega, I Aránguez, et al.
British Journal of Pharmacology
|
February 3, 2017
Role of PVAT in coronary atherosclerosis and vein graft patency: friend or foe?
M S Fernández-Alfonso, M Gil-Ortega, I Aranguez, et al.
Atherosclerosis
|
October 1, 1980
Lipids and lipoproteins in 13--18-year-old Venezuelan and American school children. Within- and cross-cultural comparisons
S Mendoza, H Nucete, A Zerpa, et al.
Physiological Research
|
December 4, 2014
Effect of fetal undernutrition and postnatal overfeeding on rat adipose tissue and organ growth at early stages of postnatal development
D Munoz-Valverde, P Rodríguez-Rodríguez, P Y Gutierrez-Arzapalo, et al.
British Journal of Pharmacology
|
June 16, 2015
Genetic predisposition to albuminuria is associated with increased arterial stiffness: role of elastin
M Gil-Ortega, C F García-Prieto, G Ruiz-Hurtado, et al.
Vascular Pharmacology
|
December 23, 2014
Mild caloric restriction reduces blood pressure and activates endothelial AMPK-PI3K-Akt-eNOS pathway in obese Zucker rats
C F García-Prieto, H Pulido-Olmo, G Ruiz-Hurtado, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
October 13, 2023
Finerenone protects against progression of kidney and cardiovascular damage in a model of type 1 diabetes through modulation of proinflammatory and osteogenic factors
M Sanz-Gómez, F J Manzano-Lista, E Vega-Martín, et al.
Page
of 3